Industry Veteran Haggar To Lead Private Equity-Backed Zentiva From Next Month
Only four months after it was carved out from Sanofi to become an independent company, Prague-based Zentiva has announced fresh leadership in the form of Nick Haggar, the 30-year industry veteran and former president of Medicines of Europe.
You may also be interested in...
Zentiva has made some high-profile changes to its senior leadership team in recent weeks. Former general manager of its Czech Republic and Slovakia business Soňa Porubská is taking on a new role as global head of corporate affairs, succeeded by Boris Sananes.
Acquiring Alvogen’s operations in central and eastern Europe will strengthen private equity-backed Zentiva’s presence in both the generics and OTC markets.
Zentiva has announced it is buying the UK’s Creo Pharmaceuticals from Amneal Pharmaceuticals as it pursues its goal of becoming a European generics leader.